Autor: |
Monserrat, Lozano-Serrano, José Alberto, García-Seco, Fernando, García-Seco, María Concepción, Lozano-Hernández, Ángela María, Seco-Segura, Jesús, Moreno-Fernández, Pedro Antonio, Muñoz-Cazallas, Carmen, Ferreiro-Vicario, Miguel Aguirre, Sánchez-Covisa |
Rok vydání: |
2012 |
Předmět: |
|
Zdroj: |
Enfermeria clinica. 23(3) |
ISSN: |
1579-2013 |
Popis: |
To assess the quality of life (QOL) and satisfaction (SF) in patients with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) compared with multiple daily insulin injections (MDI).A descriptive study was conducted to assess the QOL and SF of 68 patients on CSII or MDI treatment (1:2). The instruments used were, the Spanish version of the Diabetes Quality of Life (EsDQOL) specific for diabetes related QOL, SF-36 for general QOL, and the Diabetes Treatment Satisfaction Questionnaire (DTSQ) for SF evaluation.The EsDQOL scores for patients on CSII therapy were similar to those treated with MDI (87.20±21.11 vs 86.83±20.7, P=.86), with lower scores in the SF-36 questionnaire (66.91±15.76 vs 75.90±14.56, P=.03) except in Health Transition section, where patients treated with CSII showed higher scores (68.75±19.66 vs 57.93±17.18, p=.02). The values obtained in the DTSQ questionnaire were higher in CSII patients compared with the MDI group in last weeks (31.50±4.66 vs 27.83±6.06, p=.01) and last three months periods (13.2±6.73 vs 8.77±7.40, p=.01).Patients with T1DM on CSII therapy showed a poorer global QOL, although they felt more satisfied with their treatment than those treated with MDI. No differences in diabetes related QOL were detected between groups. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|